NCM · —

BGLC (BGLC) Stock

$1.37 -9.27% NCM: BGLC

Valuation

MetricValue
Price$1.37
Market Cap$2.76M
P/E Ratio-1.30
P/B Ratio0.47
P/S Ratio0.76
EPS (TTM)$0.00
52-Week High$15.60
52-Week Low$1.07
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-33.33%
ROA-33.33%
ROCE-37.50%
Gross Margin-57.14%
Operating Margin-42.86%
Net Margin-54.70%
Debt/Equity0.03
Current Ratio5.00

Annual Financials (USD)

Metric20212022202320242025
Revenue$13.0M$11.0M$10.0M$10.0M$7.0M
Operating Profit$1.0M$0$-3.0M$-2.0M$-3.0M
Net Profit$1.0M$0$-3.0M$-2.0M$-3.0M
EPS$0.53$-0.25$-1.53$-0.90$-1.61
Op Margin7.9%-2.7%-26.5%-16.6%-42.5%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$10.0M$9.0M$11.0M$10.0M$9.0M
Total Liabilities$2.0M$2.0M$2.0M$2.0M$1.0M
Cash$2.0M$2.0M$6.0M$4.0M$2.0M
Borrowings$0$0$0$0$0

Latest News

BioNexus Gene Lab Corp. Calls for Malaysia–China Biotechnology Cooperation to Move Beyond Trade into Co-Development GlobeNewswire · May 29, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$0$1.0M$-2.0M$-2.0M$-2.0M
Investing Cash Flow$0$-1.0M$-2.0M$0$1.0M
Financing Cash Flow$0$0$1.0M$0$0
Net Cash Flow$-1.0M$0$4.0M$-2.0M$0
Free Cash Flow$0$0$-2.0M$-2.0M$-2.0M

Valuation & Return Ratios

MetricValue
PEG Ratio
EV / EBITDA
FCF Yield-29.26%
Quick Ratio5.69
Interest Coverage
Return 1Y-55.20%
Return 3Y-98.70%
Return 5Y-99.20%

Ownership

Insiders Held35.59%
Institutions Held0.01%
Institutions Float Held0.01%
Institutional HolderSharesReport Date
UBS Group AG2312026-03-31
Wells Fargo & Company12026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ADVB $10.13 -29.46% -9.46 $10.96M 0.00%
AEONAEON Biopharma, Inc. $0.24 -5.50% -0.05 $2.80M 0.00%
APM $0.81 -0.78% -4.42 $5.15M 0.00%
CHEKCheck-Cap Ltd. $1.86 +1.64% -0.43 $10.88M 0.00%
GLTODamora Therapeutics, Inc. $21.58 -3.36% -0.17 $34.47M 0.00%

About BGLC

BGLC is led by CEO Su-Leng Tan, employs 30 people, headquartered in MY, publicly traded since 2021.

BGLC stock trades at $1.37 with a market capitalization of $2.76M. The stock is valued at a price-to-earnings (P/E) ratio of -1.30, price-to-book of 0.47, price-to-sales of 0.76. Over the past 52 weeks the stock has ranged between $1.07 and $15.60, and currently trades 91.2% below its 52-week high.

On profitability, BGLC generates a return on equity (ROE) of -33.33%, return on capital employed of -37.50%, an operating margin of -42.86%, a net profit margin of -54.70%.

Related — Stocks

BNY $152.52 -2.54% CIEN $412.39 +2.14% CBRS $188.61 -5.28% HEI.A AIRCRAFT ENGINES & ENGINE PARTS $216.35 +0.00% LEN.B GENERAL BLDG CONTRACTORS - RESIDENTIAL BLDGS $80.32 +0.00% WSO.B WHOLESALE-HARDWARE & PLUMBING & HEATING EQUIPMENT & SUPPLIES $453.37 +0.00% MKC.V MISCELLANEOUS FOOD PREPARATIONS & KINDRED PRODUCTS $51.78 +0.00% MOG.B MISC INDUSTRIAL & COMMERCIAL MACHINERY & EQUIPMENT $322.00 +0.00% MOG.A MISC INDUSTRIAL & COMMERCIAL MACHINERY & EQUIPMENT $307.91 +0.00% UHAL.B SERVICES-AUTO RENTAL & LEASING (NO DRIVERS) $45.71 +0.00% TAP.A MALT BEVERAGES $47.89 +0.00% VSXY $88.68 +0.50%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Screens featuring this stock

High ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksAll stock screens
Run Stock Screener Investing Guides